Frequently Asked Questions about E2603, an ECOG Clinical Trial for people with stage III and IV inoperable, metastatic melanoma (skin cancer)

Follow the link below to view the handout answering frequently asked questions about E2603. This is a "Double-Blind, Randomized, Placebo-Controlled Phase III Trial of Carboplatin, Paclitaxel, and BAY 43-9006 versus Carboplatin, Paclitaxel and Placebo in Patients with Unresectable Locally Advanced or Stage IV Melanoma".

Frequently Asked Questions About E2603: A Clinical trial for people with stage III and IV inoperable, metastatic melanoma (skin cancer)

The document is in Adobe Acrobat format. If you do not already have Adobe Acrobat Reader running on your computer you can download this software free of charge from the Adobe web site.